2013 ACCF/AHA Guideline for the Management of Heart Failure

References

Page 1

	Year	Citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) Scott M. Grundy JAMA Metabolic SyndromeHypertensionSecond ReportPrimary PreventionCardiovascular Disease	1993	27.9K
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> Aram V. Chobanian JAMA HypertensionCardiovascular PharmacologyPharmacotherapyBlood PressureHypertension Prevention	2003	25.4K
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation Health PolicyCardiovascular DiseaseExpert PanelHigh Blood CholesterolHyperlipidemia	2002	13.9K
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Aram V. Chobanian, George L. Bakris, Henry R. Black, Hypertension	2003	13.2K
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Scott M. Grundy, Diane M. Becker, Luther T. Clark, Civil War Book Review Cardiovascular DiseaseHigh Blood CholesterolHyperlipidemiaDyslipidemiaPublic Health	2002	12.2K
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, New England Journal of Medicine	2009	11.1K
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, New England Journal of Medicine	2011	9.3K
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Bertram Pitt, Faı̈ez Zannad, Willem J. Remme, New England Journal of Medicine	1999	9K
Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger, John H. Alexander, John J.V. McMurray, New England Journal of Medicine	2011	8.8K
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients New England Journal of Medicine	2000	8.6K

Page 1